Visceral fat accumulation, worsening insulin resistance, rising LDL cholesterol, and increasing blood pressure all contribute to this elevated risk
Funding Statement EM received funding from the UCLA Children's Discovery and innovation Institute William F
Keywords: GLP1 receptor agonists, diabetes mellitus, malnutrition, sarcopenia, sarcopenic obesity Von der Blutzuckerkontrolle zur Gewichtsreduktion Potenzial der GLP-1-RA Neue Einsatzgebiete von GLP-1-Rezeptoragonisten Glucagon-like Peptide-1-Rezeptoragonisten (GLP-1-RA) sind bei Patient/-innen mit Diabetes mellitus Typ 2 (T2DM) bereits ein etablierter Bestandteil der Therapie, insbesondere wenn gleichzeitig eine Gewichtsreduktion angestrebt wird (1)
although this can widely vary from person to person
The gut-brain axis is a bidirectional communication pathway, and when the gut environment shifts rapidly, as it does with altered eating patterns and delayed gastric emptying, the effects extend well beyond digestion
The 2026 FDA update reflects decades of re-analysis